Navigation Links
Queensland businessman is 'one in a million'
Date:2/6/2008

A retiring Queensland businessman has given the 18,700 Australians diagnosed with prostate cancer each year hope for a new treatment by donating $1 million to a Brisbane research project .

The money was donated to the Mater Medical Research Institute (MMRI), where researchers are trialling a world-first therapeutic vaccine which aims to stimulate the immune system to fight prostate cancer.

Professor Hart, Director of the MMRI, said the donation could potentially change the lives of the one in nine Australian men who will be diagnosed with this disease in their lifetime.

The body contains specialised white blood cells, called dendritic cells (DC), which initiate an immune response, Professor Hart said.

These cells direct the bodys fight against invaders like bacteria or foreign bodies but they dont always work effectively against cancer. Our work aims to trigger the immune system to kick in and destroy the prostate cancer and has the potential to revolutionise the treatment of other cancers down the track.

Prof Hart said on average research institutes only received around twenty per cent of the funding they applied for from the Federal Government.

We rely more heavily on donations and corporate support to help progress our research than many people realise and this donation will make a huge difference by enabling us to finish this phase of the trial and fast-track future trials.

Gold Coast based engineer Vince Rehbein made the $1 million donation.

Its frightening to think that 32 men are diagnosed with prostate cancer every single day in Australia, Mr Rehbein said.

I would like to see the awareness of prostate cancer, and the wonderful work thats being done by Professor Hart and his team at the MMRI, significantly increased within our community.

The trial was kick-started with a $1 million donation by Brisbane businessman, Bill Siganto in 2003.

Bills donation back in 2003 was a catalyst for me, said Mr Rehbein.

I always thought that I would do the same thing if I ever had any extra money. Today Im making that dream a reality and hopefully I will inspire other people to do the same thing.

Prostate cancer is the most common cancer in Australian males (after non-melanoma skin cancer) and more than 3,000 men die of prostate cancer in Australia each year.

Twelve patients will be involved in the Phase 1 clinical trial at the MMRI, which is designed to test the safety of the vaccine.


'/>"/>

Contact: Marnie Nichols
mnichols@mmri.mater.org.au
61-731-632-433
Research Australia
Source:Eurekalert

Related medicine news :

1. Fluoridated water for Queensland ... at last
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
4. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
5. 1.5 million children could be saved
6. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
7. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
8. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
9. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
10. £5 million investment in personalized medicines to cut patient deaths
11. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... LaserShip, a regional parcel carrier that services the ... Eastern Michigan last Friday in order to aid in the Flint water crisis. In ... a facility located in Clio, only 15 miles away from Flint. , “We have ...
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand ... within Healthcare, recently partnered with Heart City Health Center to improve ... 23 years, Heart City Health Center has provided the Elkhart community with access ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... 10 ... Brand. There were three leading bottled water brand owners that topped the list as ... enhance connectivity and optimize conversion. The premier brand was Tibet 5100, a top notch ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... welcomes S.S. Nesbitt as the latest addition to its growing list of Partner ... locations throughout the Southeast, from Orlando to Huntsville and in between. , Harnessing ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric therapists are challenged to ... shows that the Goal Attainment Scale (GAS) captures 20% more change in outcomes ... more about the Goal Attainment Scale, Education Resources Inc. is offering a course ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... and PITTSBURGH, Feb. 10, 2016 Mylan N.V. (NASDAQ, ... quarter and year ended December 31, 2015. ... Full year adjusted total revenues of $9.45 billion, up ... year; GAAP total revenues of $9.43 billion. Excluding the ... markets specialty and branded generics business (the "EPD Business"), ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
(Date:2/10/2016)... , Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC ... a 1-for-100 reverse split of its issued and outstanding ... trading on Thursday, February 11, 2016. The Company,s common ... CUSIP number 76303T308 and temporary ticker symbol "RCHAD". After ... under the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology: